Korro Bio (KRRO) Payables (2018 - 2026)

Korro Bio's Payables history runs 9 years deep, the most recent figure standing at $2.0 million for Q1 2026.

• Quarterly Payables fell 53.14% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.0 million (down 53.14% YoY) and the FY2025 annual result came in at $1.7 million, down 58.64% from the prior year.
• Payables was $2.0 million for Q1 2026 at Korro Bio, up from $1.7 million in the prior quarter.
• Across five years, Payables topped out at $7.3 million in Q4 2023 and bottomed at $338000.0 in Q3 2023.
• A 5-year average of $3.5 million and a median of $3.6 million in 2022 frame the typical range for Payables.
• Annual changes were most pronounced in 2023 — Payables tumbled 91.57% — and 2024, when it jumped 1660.36%.
• Korro Bio's Payables stood at $2.6 million in 2022, then surged by 179.46% to $7.3 million in 2023, then sank by 45.16% to $4.0 million in 2024, then tumbled by 58.64% to $1.7 million in 2025, then climbed by 18.53% to $2.0 million in 2026.
• Business Quant data shows KRRO's Payables at $2.0 million in Q1 2026, $1.7 million in Q4 2025, and $2.3 million in Q3 2025.